|
LRRC37B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.597700E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.978500E-04 |
| Normal-vs-Stage2 |
3.639400E-01 |
| Normal-vs-Stage3 |
2.798200E-02 |
| Normal-vs-Stage4 |
8.138900E-03 |
| Stage1-vs-Stage2 |
1.119210E-01 |
| Stage1-vs-Stage3 |
3.083000E-01 |
| Stage1-vs-Stage4 |
9.930000E-01 |
| Stage2-vs-Stage3 |
4.562800E-01 |
| Stage2-vs-Stage4 |
2.126600E-01 |
| Stage3-vs-Stage4 |
4.825200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.681010E-03 |
| Normal-vs-AfricanAmerican |
3.084500E-02 |
| Normal-vs-Asian |
1.757410E-04 |
| Caucasian-vs-AfricanAmerican |
5.163800E-01 |
| Caucasian-vs-Asian |
8.998000E-02 |
| AfricanAmerican-vs-Asian |
5.848000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.393210E-04 |
| Normal-vs-Female |
5.017500E-03 |
| Male-vs-Female |
4.339500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.10819999999501E-05 |
| Normal-vs-Age(41-60Yrs) |
1.649730E-02 |
| Normal-vs-Age(61-80Yrs) |
4.113600E-02 |
| Normal-vs-Age(81-100Yrs) |
7.115600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.877690E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.977700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.124400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.076000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.493900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.816500E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.185400E-01 |
| Classical-VS-Follicular |
1.181360E-01 |
| Classical-VS-Other |
4.733000E-01 |
| Classical-VS-Normal |
1.407560E-04 |
| Tall-VS-Follicular |
4.451000E-01 |
| Tall-VS-Other |
4.277000E-01 |
| Tall-VS-Normal |
3.171500E-02 |
| Follicular-VS-Other |
1.528770E-01 |
| Follicular-VS-Normal |
1.558950E-01 |
| Other-VS-Normal |
1.755010E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.575890E-02 |
| Normal-vs-N1 |
2.064600E-03 |
| N0-vs-N1 |
1.772400E-01 |
|
|
